PDL BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PDL BioPharma and buy or sell other stocks, ETFs, and their options commission-free!About PDLI
PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments.
CEOChristopher Lewis Stone
CEOChristopher Lewis Stone
Employees—
Employees—
HeadquartersReno, Nevada
HeadquartersReno, Nevada
Founded1986
Founded1986
Employees—
Employees—
PDLI Key Statistics
Market cap233.85M
Market cap233.85M
Price-Earnings ratio-1.81
Price-Earnings ratio-1.81
Dividend yield—
Dividend yield—
Average volume6.15M
Average volume6.15M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.52
52 Week high$2.52
52 Week low$1.61
52 Week low$1.61
Stock Snapshot
As of today, PDL BioPharma(PDLI) shares are valued at $2.47. The company's market cap stands at 233.85M, with a P/E ratio of -1.81.
On 2025-12-04, PDL BioPharma(PDLI) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for PDL BioPharma(PDLI) stock has reached 0, versus its average volume of 6.15M.
Over the past 52 weeks, PDL BioPharma(PDLI) stock has traded between a high of $2.52 and a low of $1.61.
Over the past 52 weeks, PDL BioPharma(PDLI) stock has traded between a high of $2.52 and a low of $1.61.
People also own
Based on the portfolios of people who own PDLI. This list is generated using Robinhood data, and it’s not a recommendation.